(19)
(11) EP 2 994 129 A1

(12)

(43) Date of publication:
16.03.2016 Bulletin 2016/11

(21) Application number: 13884110.1

(22) Date of filing: 07.05.2013
(51) International Patent Classification (IPC): 
A61K 31/403(2006.01)
(86) International application number:
PCT/US2013/039791
(87) International publication number:
WO 2014/182279 (13.11.2014 Gazette 2014/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(71) Applicants:
  • Euthymics Bioscience, Inc.
    Cambridge, MA 02141 (US)
  • McKinney, Anthony, Alexander
    Cambridge, MA 02141 (US)
  • Bymaster, Franklin, Porter
    Brownsburg, ID 46112 (US)

(72) Inventors:
  • MCKINNEY, Anthony, Alexander
    Cambridge, MA 02141 (US)
  • BYMASTER, Franklin, Porter
    Brownsburg, ID 46112 (US)

(74) Representative: Pharma Concepts GmbH 
Unterer Rheinweg 50
4057 Basel
4057 Basel (CH)

   


(54) USE OF (+)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE TO TREAT ADDICTIVE AND ALCOHOL-RELATED DISORDERS